WESPAC Advisors SoCal LLC lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 174.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,858 shares of the exchange traded fund’s stock after buying an additional 8,816 shares during the period. WESPAC Advisors SoCal LLC’s holdings in SPDR S&P Biotech ETF were worth $1,770,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at $27,000. Intesa Sanpaolo Wealth Management acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $30,000. SHP Wealth Management acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $31,000. Legacy Wealth Managment LLC ID bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $32,000. Finally, Smartleaf Asset Management LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $32,000.
SPDR S&P Biotech ETF Price Performance
Shares of SPDR S&P Biotech ETF stock opened at $140.72 on Friday. The stock has a market capitalization of $8.98 billion, a P/E ratio of 11.47 and a beta of 0.85. The company has a 50-day simple moving average of $133.56 and a 200 day simple moving average of $127.70. SPDR S&P Biotech ETF has a 12-month low of $80.90 and a 12-month high of $143.46.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
